SCHEMBL24074428

SCHEMBL24074428

COC(=O)Oc1ccccc1C(=O)Nc1ncc(N=O)s1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 9/20 0.53
▸ RAB9A P51151 9/20 0.53
▸ ALDH1A1 P00352 7/20 0.53
▸ SMN1; SMN2 Q16637 6/20 0.53
▸ MEN1 O00255 4/20 0.53
▸ KMT2A Q03164 4/20 0.53
▸ LMNA P02545 3/20 0.53
▸ MAPT P10636 3/20 0.53
▸ HSD17B10 Q99714 2/20 0.53
▸ PKM P14618 2/20 0.53
▸ MAPK1 P28482 2/20 0.53
▸ TP53 P04637 2/20 0.53
▸ MLNR O43193 1/20 0.53
▸ NR1I2 O75469 1/20 0.53
▸ ABCB11 O95342 1/20 0.53
▸ ADRB2 P07550 1/20 0.53
▸ CHRM2 P08172 1/20 0.53
▸ ADRB1 P08588 1/20 0.53
▸ CYP3A4 P08684 1/20 0.53
▸ ADRA2A P08913 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13044208 0.89 ALDH1A1 (0.65) NPC1RAB9AALDH1A1SMN1; SMN2MEN1
SCHEMBL13045038 0.89 RAB9A (0.58) NPC1RAB9AALDH1A1SMN1; SMN2MEN1
SCHEMBL26357857 0.87 NPC1 (0.54) NPC1RAB9AALDH1A1SMN1; SMN2MEN1
SCHEMBL24074427 0.87 NPC1 (0.52) NPC1RAB9AALDH1A1SMN1; SMN2MEN1
SCHEMBL24073805 0.86 NPC1 (0.47) NPC1RAB9AALDH1A1SMN1; SMN2MEN1
SCHEMBL24072392 0.85 ALDH1A1 (0.61) NPC1RAB9AALDH1A1SMN1; SMN2MEN1
SCHEMBL25063039 0.82 ALDH1A1 (0.54) NPC1RAB9AALDH1A1SMN1; SMN2MEN1
SCHEMBL25063130 0.81 KCNK3 (0.47) NPC1RAB9AALDH1A1SMN1; SMN2MEN1
SCHEMBL24072305 0.81 CCNE1 (0.49) NPC1RAB9AALDH1A1SMN1; SMN2MEN1
SCHEMBL24074515 0.81 KAT2B (0.44) NPC1RAB9AALDH1A1SMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240066136-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS CULLGEN (SHANGHAI), INC. (CN) 2024-02-29 — — US disclosed
US-20230057177-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS CULLGEN (SHANGHAI), INC. (CN) 2023-02-23 — — US disclosed
WO-2021239117-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS CULLGEN (SHANGHAI) , INC. (CN) 2021-12-02 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240066136-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS DDB1, DCLRE1A, MDM2 NPC1 3949/4885RAB9A 3280/4885ALDH1A1 1427/4885
US-20230057177-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS DDB1, DCLRE1A, MDM2 NPC1 3949/4885RAB9A 3280/4885ALDH1A1 1427/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback